Yuri Matsumoto

1.7k total citations
53 papers, 1.3k citations indexed

About

Yuri Matsumoto is a scholar working on Oncology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, Yuri Matsumoto has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 27 papers in Obstetrics and Gynecology and 18 papers in Reproductive Medicine. Recurrent topics in Yuri Matsumoto's work include Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (14 papers) and Inflammatory Biomarkers in Disease Prognosis (14 papers). Yuri Matsumoto is often cited by papers focused on Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (14 papers) and Inflammatory Biomarkers in Disease Prognosis (14 papers). Yuri Matsumoto collaborates with scholars based in Japan and United States. Yuri Matsumoto's co-authors include Seiji Mabuchi, Tadashi Kimura, Hiromasa Kuroda, Mahiru Kawano, Katsumi Kozasa, Kenjiro Sawada, Tomoyuki Sasano, Ryoko Takahashi, Eriko Yokoi and Naoko Komura and has published in prestigious journals such as Nature Communications, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Yuri Matsumoto

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuri Matsumoto Japan	22	675	494	369	324	248	53	1.3k
Mahiru Kawano Japan	21	502 0.7×	497 1.0×	242 0.7×	321 1.0×	201 0.8×	39	1.1k
Tomoyuki Sasano Japan	21	558 0.8×	473 1.0×	268 0.7×	249 0.8×	141 0.6×	44	1.1k
Kari L. Ring United States	20	500 0.7×	208 0.4×	467 1.3×	269 0.8×	302 1.2×	74	1.3k
Thaïs Baert Belgium	16	400 0.6×	260 0.5×	219 0.6×	149 0.5×	102 0.4×	47	955
Philippe Van Trappen Belgium	16	663 1.0×	82 0.2×	477 1.3×	517 1.6×	228 0.9×	41	1.5k
Mark E. Borowsky United States	13	329 0.5×	237 0.5×	165 0.4×	339 1.0×	103 0.4×	24	896
Tilmann Lantzsch Germany	14	294 0.4×	119 0.2×	144 0.4×	237 0.7×	209 0.8×	26	819
Ayumi Hongo Japan	17	370 0.5×	180 0.4×	146 0.4×	508 1.6×	177 0.7×	31	944
Mana Taki Japan	10	546 0.8×	484 1.0×	97 0.3×	275 0.8×	178 0.7×	46	1.0k
Alexandra Sebastianelli Canada	21	178 0.3×	120 0.2×	635 1.7×	333 1.0×	156 0.6×	42	1.1k

Countries citing papers authored by Yuri Matsumoto

Since Specialization

Citations

This map shows the geographic impact of Yuri Matsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri Matsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri Matsumoto more than expected).

Fields of papers citing papers by Yuri Matsumoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri Matsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri Matsumoto. The network helps show where Yuri Matsumoto may publish in the future.

Co-authorship network of co-authors of Yuri Matsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri Matsumoto. A scholar is included among the top collaborators of Yuri Matsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri Matsumoto. Yuri Matsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mabuchi, Seiji, Yuri Matsumoto, Ayako Miyazaki, et al.. (2022). Iliac artery-enteric fistula developed during bevacizumab-containing chemotherapy for recurrent cervical cancer: A case report and literature review. Gynecologic Oncology Reports. 40. 100938–100938. 2 indexed citations

Mabuchi, Seiji, Naoko Komura, Michiko Kodama, et al.. (2022). Impact of lymphadenectomy in patients with locally recurrent or persistent cervical cancer treated with salvage hysterectomy. Journal of obstetrics and gynaecology research. 49(2). 717–724. 2 indexed citations

Mabuchi, Seiji, Kotaro Shimura, & Yuri Matsumoto. (2021). The significance of post-radiotherapy parametrial involvement and the necessity of parametrial resection in locally-recurrent or persistent cervical cancer developed after radiotherapy. Journal of Gynecology Obstetrics and Human Reproduction. 50(10). 102190–102190. 3 indexed citations

Isohashi, Fumiaki, Yuichi Akino, Yuri Matsumoto, et al.. (2021). Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer. Journal of Radiation Research. 62(3). 494–501. 1 indexed citations

Komura, Naoko, Seiji Mabuchi, Kotaro Shimura, et al.. (2020). Significance of Pretreatment C-Reactive Protein, Albumin, and C-Reactive Protein to Albumin Ratio in Predicting Poor Prognosis in Epithelial Ovarian Cancer Patients. Nutrition and Cancer. 73(8). 1357–1364. 21 indexed citations

Yokoi, Eriko, Seiji Mabuchi, Naoko Komura, et al.. (2020). Incorporation of pretreatment leukocytosis and thrombocytosis into the FIGO staging system for prognosis in surgically treated endometrial cancer. International Journal of Gynecology & Obstetrics. 151(2). 272–278. 3 indexed citations

Mabuchi, Seiji, Yuri Matsumoto, & Sho Matsubara. (2020). New Peritoneal Traction Device for Laparoscopic Paraaortic Lymphadenectomy. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 24(1). e2019.00062–e2019.00062. 1 indexed citations

Matsumoto, Yuri, Seiji Mabuchi, Fumiaki Isohashi, et al.. (2020). Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients. International Journal of Clinical Oncology. 25(6). 1170–1177. 5 indexed citations

Komura, Naoko, Seiji Mabuchi, Eriko Yokoi, et al.. (2019). Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer. International Journal of Gynecological Cancer. 29(6). 1057–1063. 8 indexed citations

10.

Sasano, Tomoyuki, Seiji Mabuchi, Katsumi Kozasa, et al.. (2018). The Highly Metastatic Nature of Uterine Cervical/Endometrial Cancer Displaying Tumor-Related Leukocytosis: Clinical and Preclinical Investigations. Clinical Cancer Research. 24(16). 4018–4029. 40 indexed citations

11.

Yokoi, Eriko, Seiji Mabuchi, Kotaro Shimura, et al.. (2018). Lurbinectedin (PM01183), a selective inhibitor of active transcription, effectively eliminates both cancer cells and cancer stem cells in preclinical models of uterine cervical cancer. Investigational New Drugs. 37(5). 818–827. 20 indexed citations

12.

Takahashi, Ryoko, Seiji Mabuchi, Hiromasa Kuroda, et al.. (2017). The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer. International Journal of Gynecological Cancer. 27(7). 1399–1407. 18 indexed citations

13.

Kuroda, Hiromasa, Seiji Mabuchi, Katsumi Kozasa, et al.. (2017). PM01183 Inhibits Myeloid-Derived Suppressor Cells In Vitro and In Vivo. Immunotherapy. 9(10). 805–817. 16 indexed citations

14.

Matsumoto, Yuri, Seiji Mabuchi, Katsumi Kozasa, et al.. (2017). The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy. Gynecologic Oncology. 145(3). 469–475. 30 indexed citations

15.

Takahashi, Ryoko, Seiji Mabuchi, Mahiru Kawano, et al.. (2015). Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study. Gynecologic Oncology. 137(1). 112–118. 40 indexed citations

16.

Hisamatsu, Takeshi, Seiji Mabuchi, Yuri Matsumoto, et al.. (2013). Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 12(7). 1367–1377. 37 indexed citations

17.

Matsuo, Koji, Seiji Mabuchi, Mika Okazawa, et al.. (2013). Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer. British Journal of Cancer. 108(6). 1348–1357. 16 indexed citations

18.

Mabuchi, Seiji, Yuri Matsumoto, Toshimitsu Hamasaki, et al.. (2012). Elevated White Blood Cell Count at the Time of Recurrence Diagnosis Is an Indicator of Short Survival in Patients With Recurrent Cervical Cancer. International Journal of Gynecological Cancer. 22(9). 1545–1551. 29 indexed citations

19.

Mabuchi, Seiji, Yuri Matsumoto, Eiichi Morii, Ken‐ichirou Morishige, & Tadashi Kimura. (2010). The First 2 Cases of Granulocyte Colony-stimulating Factor Producing Adenocarcinoma of the Uterine Cervix. International Journal of Gynecological Pathology. 29(5). 483–487. 15 indexed citations

20.

Sugiura, Yoshiki, et al.. (2000). Successful treatment of reactive hemophagocytic syndrome by plasmapheresis and high-dose γ-globulin in a patient with systemic lupus erythematosus. Modern Rheumatology. 10(4). 263–266. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact